News
Yonhap News Agency on MSN5h
Celltrion expects minimal impact from Trump's drug pricing orderCelltrion Inc., a leading South Korean biopharmaceutical company, said Thursday its business will remain largely unaffected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback